Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients

por Hurst, N G, Stocken, D D, Wilson, S, Keh, C, Wakelam, M J O, Ismail, T
Publicado 2007

Reply: Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients

por Hurst, N G, Stocken, D D, Wilson, S, Keh, C, Wakelam, M J O, Ismail, T
Publicado 2008

Assessing the value of matrix metalloproteinase 9 (MMP9) in improving the appropriateness of referrals for colorectal cancer

por Damery, S, Nichols, L, Holder, R, Ward, S T, Warmington, S, Wilson, S, Wakelam, M J, James, J, Ismail, T
Publicado 2013

Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test

por Wilson, S, Damery, S, Stocken, D D, Dowswell, G, Holder, R, Ward, S T, Redman, V, Wakelam, M J, James, J, Hobbs, F D R, Ismail, T
Publicado 2012

Identification of serum biomarkers for colon cancer by proteomic analysis

por Ward, D G, Suggett, N, Cheng, Y, Wei, W, Johnson, H, Billingham, L J, Ismail, T, Wakelam, M J O, Johnson, P J, Martin, A
Publicado 2006

Runx1 Orchestrates Sphingolipid Metabolism and Glucocorticoid Resistance in Lymphomagenesis

por Kilbey, A., Terry, A., Wotton, S., Borland, G., Zhang, Q., Mackay, N., McDonald, A., Bell, M., Wakelam, M.J.O., Cameron, E.R., Neil, J.C.
Publicado 2017